- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Temporary uterus transplants to benefit women to give birth in US
After completing a practice run on a organ donor; first with the kidney transplant, a team of six doctors are reported to have done a rare surgery of a uterus transplant from the same donor. This group of Surgeons at the Cleveland Clinic hopes to achieve the uterus transplant milestone, giving hope to many women who can thus become pregnant and give birth.
Cases of recipients, who were born with without a uterus, had it removed or have uterine damage, will benefit from such temporarily transplant; set with a single-fold purpose of giving birth to one or two babies. Once the woman is able to conceive once or twice, the uterus will be removed, and clinically, she won't be required to take the transplant anti-rejection drugs.
The risks anti-rejection drugs, and the surgery itself is what these healthy women will be exposed to, while undergoing the transplant they choose. The risk factor doesn't stop here. The high risk pregnancies, accompanied by the fact of the fetuses bearing the risk of anti-rejection drugs in the womb also need to be strongly considered. Specialists attention from both -reproductive medicine and transplant surgery field will be required by the patient.
However, the procedure is likely to benefit 50,000 women in the US. Eight women from around the country have begun the screening process at the Cleveland Clinic, hoping to be selected for transplants. One, a 26-year-old with two adopted children, said she still wanted a chance to become pregnant and give birth. "I crave that experience," she said. "I want the morning sickness, the backaches, the feet swelling. I want to feel the baby move. That is something I've wanted for as long as I can remember." She asked that her name and home town be withheld to protect her family's privacy, as reported by the Times of India.
Dr Andreas G Tzakis, the driving force behind the project, said, "There are women who won't adopt or have surrogates, for reasons that are personal, cultural or religious." Dr Tzakis is the director of solid organ transplant surgery at a Cleveland Clinic hospital in Weston, Florida. "These women know exactly what this is about," he said, "Our job is to make it as safe and successful as possible." The hospital plans to perform the procedure 10 times, as an experiment, and then decide whether to continue.
Sweden is the only country where uterine transplants have been completed successfully -all at the University of Gothenburg with an uterus from a live donor.
Cases of recipients, who were born with without a uterus, had it removed or have uterine damage, will benefit from such temporarily transplant; set with a single-fold purpose of giving birth to one or two babies. Once the woman is able to conceive once or twice, the uterus will be removed, and clinically, she won't be required to take the transplant anti-rejection drugs.
The risks anti-rejection drugs, and the surgery itself is what these healthy women will be exposed to, while undergoing the transplant they choose. The risk factor doesn't stop here. The high risk pregnancies, accompanied by the fact of the fetuses bearing the risk of anti-rejection drugs in the womb also need to be strongly considered. Specialists attention from both -reproductive medicine and transplant surgery field will be required by the patient.
However, the procedure is likely to benefit 50,000 women in the US. Eight women from around the country have begun the screening process at the Cleveland Clinic, hoping to be selected for transplants. One, a 26-year-old with two adopted children, said she still wanted a chance to become pregnant and give birth. "I crave that experience," she said. "I want the morning sickness, the backaches, the feet swelling. I want to feel the baby move. That is something I've wanted for as long as I can remember." She asked that her name and home town be withheld to protect her family's privacy, as reported by the Times of India.
Dr Andreas G Tzakis, the driving force behind the project, said, "There are women who won't adopt or have surrogates, for reasons that are personal, cultural or religious." Dr Tzakis is the director of solid organ transplant surgery at a Cleveland Clinic hospital in Weston, Florida. "These women know exactly what this is about," he said, "Our job is to make it as safe and successful as possible." The hospital plans to perform the procedure 10 times, as an experiment, and then decide whether to continue.
Sweden is the only country where uterine transplants have been completed successfully -all at the University of Gothenburg with an uterus from a live donor.
Next Story